{
  "id": 18155451,
  "title": "Sanofi stops development of Nurix-partnered immune drug",
  "url": "https://urgent.news/2026/11/04/sanofi-stops-development-of-nurix-partnered-immune-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T17:18:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/sanofi-discontinue-development-nurix-stat6-degrader-eczema/873697/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The decision sparked a sell-off in Nurix shares as well as analyst debate about the prospects of drugs designed to degrade a tough-to-reach protein called STAT6.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}